Palisade Bio (PALI) Capital Expenditures (QoQ) (2010 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 200.00% |
| Dec 31, 2017 | -69.07% |
| Jun 30, 2016 | 471.93% |
| Mar 31, 2016 | -69.62% |
| Dec 31, 2015 | 49.28% |
| Sep 30, 2015 | -59.74% |
| Jun 30, 2015 | 398.17% |
| Mar 31, 2015 | -55.06% |
| Dec 31, 2014 | 31.91% |
| Sep 30, 2014 | -20.36% |
| Jun 30, 2014 | -69.39% |
| Mar 31, 2014 | 1,629.25% |
| Dec 31, 2013 | -94.34% |
| Sep 30, 2013 | 2,939.24% |
| Jun 30, 2013 | 125.60% |
| Mar 31, 2013 | -81.63% |
| Dec 31, 2012 | 1,420.57% |
| Sep 30, 2012 | -98.00% |
| Dec 31, 2011 | 81.61% |
| Sep 30, 2011 | -96.11% |
| Jun 30, 2011 | 162.69% |
| Mar 31, 2011 | 3.78% |
| Dec 31, 2010 | 2,940.31% |